For this reason, the detection of problematic anxiety via the use of an effective screening tool may be important in screening for risk of problematic anxiety, prevention, early intervention, and treatment in the field of perinatal mental health. Anxiety can also negatively affect the behavioral development, emotional and cognitive status of the child, and the mother-infant relationship. Maternal health can be negatively impacted by untreated anxiety. The Arabic translated version of the PASS showed reasonably adequate validity and reliability and can be used to screen for anxiety disorder among women in the perinatal phase. PASS significantly correlated with EPDS-10 (rho=0.46), GHQ-12(rho=0.58), the three components of DASS-21 (0.47, 0.50, and 0.43 respectively), and experiencing adverse life events. Cronbach’s Alpha value for the scale was 0.78 and test retest correlation coefficient was 0.94.
The scale loaded on four components: acute anxiety, social anxiety, and dissociation specific fears and trauma general anxiety and adjustment and perfectionism and control. ResultsĬontent Validity Index (CVI) and Content Validity Ratio (CVR) were.
Content validity, factor analysis, internal consistency, and test retest reliability were assessed. Two hundred seventeen women in the antenatal and postnatal phase participated (92 antenatal and 125 postnatal) answered to PASS, GHQ12, EPDS-10, and DASS-21.
This study assesses the validity and reliability of the “Perinatal Anxiety Screening Scale” (PASS) in the Arabic language. Assessing the severity of perinatal anxiety will help monitor the progress of the patient through the stages of anxiety and facilitated the treatment. Anxiety among women in the perinatal period is common.
0 kommentar(er)
